Fibrolamellar Cancer Foundation Research Grant Program

About this program

The Fibrolamellar Cancer Foundation (FCF) funds innovative research aimed at improving understanding, diagnosis, epidemiology, and treatment of fibrolamellar carcinoma (FLC), with emphasis on projects that could lead to novel therapies, clinical trials, or a cure. Applicants must be employed by an institution engaged in health-related research and propose studies focused specifically on FLC. Collaboration and open sharing of data and resources are required, and funded researchers must submit semiannual financial and scientific progress reports; applications are reviewed by March 1, July 1, and November 1 annually.